Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
05:00pm, Wednesday, 20'th Mar 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive r
Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research
12:36pm, Monday, 18'th Mar 2024
Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future.
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
06:00am, Monday, 18'th Mar 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw® offering, t
Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
08:00am, Friday, 15'th Mar 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagen
Revvity (RVTY) Q4 Earnings Top, EPS View Above Expectation
11:45am, Thursday, 01'st Feb 2024
Revvity's (RVTY) fourth-quarter results showcase the decline in segmental revenues. However, the company's earnings and revenues beat their respective estimates.
Compared to Estimates, Revvity (RVTY) Q4 Earnings: A Look at Key Metrics
10:37am, Thursday, 01'st Feb 2024
The headline numbers for Revvity (RVTY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Revvity, Inc. (RVTY) CEO Prahlad Singh presents at 42nd Annual J.P. Morgan Healthcare Conference (Transcript)
05:35pm, Tuesday, 09'th Jan 2024
Revvity, Inc. (RVTY) CEO Prahlad Singh presents at 42nd Annual J.P. Morgan Healthcare Conference (Transcript)
Revvity (RVTY) Launches New Molecular Testing for Newborns
09:01am, Friday, 01'st Dec 2023
Revvity's (RVTY) EONIS Q System is set to transform SMA and SCID testing, advancing global healthcare for infants.
Revvity, Inc. (RVTY) Q3 2023 Earnings Call Transcript
01:51am, Sunday, 05'th Nov 2023
Revvity, Inc. (NYSE:RVTY ) Q3 2023 Earnings Conference Call October 30, 2023 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President Investor Relations Prahlad Singh - President and C
Why Revvity Stock Plunged Today
05:12pm, Monday, 30'th Oct 2023
Revvity announced weaker-than-expected third-quarter results and lowered its full-year outlook. CEO Prahlad Singh blamed today's "increasingly challenging end market environment," but insists the comp
Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View
01:32pm, Monday, 30'th Oct 2023
Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective estimates.
Revvity tumbles on 3Q earnings miss; revised guidance in “increasingly challenging” environment
11:48am, Monday, 30'th Oct 2023
Revvity Inc posted third-quarter revenue and earnings that fell short of market expectations and lowered its full-year guidance in what it described as an increasingly challenging end-market environme
Revvity Stock Tumbles 18% as Demand From Pharma and Biotech Customers Falls
10:58am, Monday, 30'th Oct 2023
Revvity posts third-quarter earnings of $1.18 a share, 1 cent below estimates. Revenue of $670.7 million also came in below forecasts.
Revvity's stock tumbles to lead the S&P 500 losers after earnings miss, lowered outlook
09:25am, Monday, 30'th Oct 2023
Shares of Revvity Inc. RVTY, -1.09% tumbled 14.2% toward a 3 1/2-year low Monday, enough to pace the S&P 500's SPX, +0.72% premarket decliners, after the health sciences company missed third-quarter e
Revvity (RVTY) Misses Q3 Earnings and Revenue Estimates
08:16am, Monday, 30'th Oct 2023
Revvity (RVTY) came out with quarterly earnings of $1.18 per share, missing the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.51 per share a year ago.
